RE:4050 Phase I valuation, and clinical trial risks.1402 wasn't toxic, and 4050 he's in the same family. Also, if they wouldn't have an idea about toxicity in 4050, don't you think that Dr Moran would have made the move right now? I don't think the guy is here for fibrinogen. Hope I'm not wrong...